Skip to content
Screener

Collegium Pharmaceutical, Inc. COLL Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
$22M-40.5%
Scilex Holding Company logo
Scilex Holding CompanySCLX
$14.18M+592%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
6.9%0.0pp
Bioventus logo
BioventusBVS
5.2%0.0pp
Dogwood Therapeutics logo
Dogwood TherapeuticsDWTX
$146.75K-24.3%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
9.3%0.0pp

Segments

By geography

See full
Stoughton, Massachusetts$4.17M

Other financials

Income statement

See full
Revenue$199.9M+6.3%
Gross profit$110.3M+1.8%
Operating income$3.7M-89.5%
Net income-$15.1M-226%
EPS (diluted)-$0.46-235%

Balance sheet

See full
Cash & equivalents$150.4M+8.8%
Total debt$5.0M-19.8%
Total equity$311.9M+34.3%
Total assets$2.1B+34.1%

Cash flow

See full
Operating cash flow$71.3M-1.5%
CapEx$496.0K+663%
Free cash flow$70.8M-2.1%

Valuation

See full
Market cap$882.2M-22.5%
Enterprise value$736.79M-26.8%
P/E18.4×-13.0×
P/S1.1×-0.5×

Profitability

See full
Gross margin60%+3.3pp
Operating margin19.5%+1.1pp
Net margin5.9%+0.8pp
FCF margin40.6%+10.8pp

Returns & leverage

See full
Return on equity17.6%+1.4pp
Debt / equity0.0×
Current ratio-0.2×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:34 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053851
Line itemJune 30,2026December 31,2025
Restricted cash19,85019,850
Total current assets608,014691,411
Property and equipment, net10,65312,013
Operating lease assets3,7914,187
Intangible assets, net1,186,084669,510
Restricted cash1,0601,056
Deferred tax assets120,774112,539
Other noncurrent assets15,23720,193

Item 1. Condensed Consolidated Financial Statements (Unaudited).

FAQ

What is Collegium Pharmaceutical, Inc.'s operating lease ROU assets?
Collegium Pharmaceutical, Inc. (COLL) reported operating lease ROU assets of $3.79M in Q2 2026.
How has Collegium Pharmaceutical, Inc.'s operating lease ROU assets changed year-over-year?
Collegium Pharmaceutical, Inc.'s operating lease ROU assets decreased by 28.0% year-over-year, from $5.26M to $3.79M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s operating lease ROU assets has grown at a -13.0% compound annual growth rate (CAGR), from $8.39M to $4.19M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Collegium Pharmaceutical, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude